Inventor · disambiguated record
John C. Timmer
Also filed as: TIMMER JOHN · TIMMER JOHN C
41 granted patents·32 pending applications·214 citations·filing 2012–2025
97Inventor score
Top patents by PatentIndex Score
73 records- 0197US9045541B2CD47 antibodies and methods of use thereofINHIBRX LLC·Filed 2013·Granted Jun 2, 2015·78 cites·21 claims
- 0296US10723785B2Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2018·Granted Jul 28, 2020·9 cites·15 claims
- 0395US9663575B2CD47 antibodies and methods of use thereofINHIBRX LP·Filed 2015·Granted May 30, 2017·22 cites·22 claims
- 0493US10730929B2Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2015·Granted Aug 4, 2020·5 cites·15 claims
- 0592US11866507B2Multispecific polypeptide constructs having constrained CD3 binding and methods of using the sameINHIBRX INC·Filed 2018·Granted Jan 9, 2024·8 cites·10 claims
- 0692US8980266B2Serpin fusion polypeptides and methods of use thereofECKELMAN BRENDAN·Filed 2012·Granted Mar 17, 2015·23 cites·22 claims
- 0791US10526397B2Non-immunogenic single domain antibodiesINHIBRX INC·Filed 2016·Granted Jan 7, 2020·10 cites·24 claims
- 0890US9920109B2Serpin fusion polypeptides and methods of purification thereofINHIBRX LLC·Filed 2013·Granted Mar 20, 2018·9 cites·14 claims
- 0988US12043667B2CLEC12a binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2020·Granted Jul 23, 2024·2 cites·27 claims
- 1088US11046752B2Serpin fusion polypeptides and methods of use thereofINHIBRX LP·Filed 2019·Granted Jun 29, 2021·3 cites·7 claims
- 1188US10501551B2Multivalent and multispecific 41BB-binding fusion proteinsINHIBRX INC·Filed 2017·Granted Dec 10, 2019·7 cites·64 claims
- 1288US10400029B2Serpin fusion polypeptides and methods of use thereofINHIBRX LP·Filed 2014·Granted Sep 3, 2019·6 cites·7 claims
- 1388US9914765B2WAP domain fusion polypeptides and methods of use thereofINHIBRX LLC·Filed 2015·Granted Mar 13, 2018·10 cites·7 claims
- 1487US11560428B2CD33-binding polypeptides and uses thereofINHIBRX INC·Filed 2020·Granted Jan 24, 2023·2 cites·37 claims
- 1587US2025011394A1Serpin fusion polypeptides and methods of use thereofSANOFI AATD INC·Filed 2024·Application pending·0 cites
- 1686US12331126B2OX40-binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2024·Granted Jun 17, 2025·0 cites·47 claims
- 1784US11117972B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 1884US10093742B2Multispecific GITR-binding fusion proteins and methods of use thereofINHIBRX INC·Filed 2016·Granted Oct 9, 2018·4 cites·57 claims
- 1984US2025250349A1Uses of pdl1-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2083US10308720B2Multivalent and multispecific DR5-binding fusion proteinsINHIBRX INC·Filed 2016·Granted Jun 4, 2019·3 cites·24 claims
- 2183US8986688B2WAP domain fusion polypeptides and methods of use thereofTIMMER JOHN·Filed 2012·Granted Mar 24, 2015·11 cites·24 claims
- 2283US2024376220A1Multivalent and Multispecific DR5-Binding Fusion ProteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2381US12297271B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2024·Granted May 13, 2025·0 cites·18 claims
- 2481US12187804B2Multivalent and multispecific 41BB-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2022·Granted Jan 7, 2025·0 cites·12 claims
- 2581US2025223338A1Non-immunogenic single domain antibodiesINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2679US12331132B2Multispecific polypeptide constructs having constrained CD3 binding and related methods and usesINHIBRX BIOSCIENCES INC·Filed 2023·Granted Jun 17, 2025·0 cites·21 claims
- 2778US12012459B2OX40-binding polypeptides and uses thereofINHIBRX INC·Filed 2022·Granted Jun 18, 2024·0 cites·39 claims
- 2877US2025059279A1CD33-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2976US11976126B2Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cellsINHIBRX INC·Filed 2021·Granted May 7, 2024·0 cites·24 claims
- 3076US11965017B2Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2020·Granted Apr 23, 2024·0 cites·5 claims
- 3176US2025011436A1CLEC12a Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3275US2025092137A1Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3374US11827691B2Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2020·Granted Nov 28, 2023·0 cites·11 claims
- 3474US2025361319A1Multispecific polypeptide constructs having constrained cd3 binding and related methods and usesINHIBRX BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3573US12084502B2CD33-binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2022·Granted Sep 10, 2024·0 cites·27 claims
- 3673US2024166744A1Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereofINHIBRX INC·Filed 2023·Application pending·0 cites
- 3773US2024101704A1Multispecific polypeptide constructs having constrained cd3 binding and methods of using the sameINHIBRX INC·Filed 2023·Application pending·0 cites
- 3872US12227584B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX BIOSCIENCES INC·Filed 2021·Granted Feb 18, 2025·0 cites·18 claims
- 3972US11945869B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX INC·Filed 2021·Granted Apr 2, 2024·0 cites·17 claims
- 4072US11208485B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX INC·Filed 2019·Granted Dec 28, 2021·0 cites·28 claims
- 4171US11566078B2PDL1-binding proteinsINHIBRX INC·Filed 2019·Granted Jan 31, 2023·0 cites·22 claims
- 4271US2021317205A1Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereofINHIBRX INC·Filed 2021·Application pending·0 cites
- 4370US11447556B2OX40-binding polypeptides and uses thereofINHIBRX INC·Filed 2019·Granted Sep 20, 2022·0 cites·60 claims
- 4470US11117973B2Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasmsINHIBRX INC·Filed 2019·Granted Sep 14, 2021·0 cites·39 claims
- 4570US2020102371A1Serpin fusion polypeptides and methods of use thereofINHIBRX LP·Filed 2019·Application pending·0 cites
- 4669US2022324944A1Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2021·Application pending·0 cites
- 4766US11919963B2CD123-binding polypeptides and uses thereofINHIBRX INC·Filed 2022·Granted Mar 5, 2024·0 cites·28 claims
- 4866US2020140525A1Non-Immunogenic Single Domain AntibodiesINHIBRX INC·Filed 2019·Application pending·0 cites
- 4965US10745466B2Type III secretion system targeting moleculesINHIBRX INC·Filed 2019·Granted Aug 18, 2020·0 cites·33 claims
- 5063US10844129B2Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acidsINHIBRX INC·Filed 2018·Granted Nov 24, 2020·0 cites·34 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John C. Timmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →